Acute Leukemia in Relapse
3
0
0
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Petiveria Alliacea Preparation
Research Leaders
6 sponsors active, led by Hospital Universitario San Ignacio
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
33.3%
1 terminated out of 3 trials
0.0%
-86.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (3)
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)
Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia
Research Network
Common Treatments
- Petiveria Alliacea Preparation1
- Tcrαβcd45radepleted Haploidentical Hematopoietic Stem Cell Transplantation Haplohsct1
- Anticd123 Cart Treatment1
Active Sponsors
- Hospital Universitario San Ignacio1
- Nanjing Legend Biotech Co.1
- Second Affiliated Hospital of Xi'an Jiaotong University1
- Pontificia Universidad Javeriana1
- Miltenyi Biotec B.V. & Co. KG1
Top Investigators
Second Affiliated Hospital of Xi'an Jiaotong University
Related Conditions
- Acute Leukemia3
- Acute Myeloid Leukemia2
- Acute Leukemia Refractory1
- Colorectal Neoplasms1
- All Acute Blymphoblastic Leukemia1